A federal appeals court has upheld the securities fraud conviction against former drug company CEO Martin Shkreli.
Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran.
A message requesting comment was emailed to Shkreli's legal team Thursday.
Before his arrest, Shkreli was best known for buying the rights to a lifesaving drug at another company in 2014 and raising the price from $13.50 to $750 per pill.
He also gained notoriety for attacking critics on social media under the moniker "Pharma Bro." He was barred from Twitter for posts about a female journalist.
